THE WHAT? The UK’s Advertising Standards Authority (ASA) has upheld a ruling against Beautaholics Ltd after finding that its Meta and website ads for the RejuvaLux LED face mask made medicinal claims without appropriate authorisation.
THE DETAILS The ASA’s Active Ad Monitoring system flagged the ads as part of a broader review of LED skincare mask promotions. The Meta ad and website copy claimed the device provided “clinically proven light therapy” and “targeted solutions” for acne and rosacea — statements the ASA deemed medicinal.
While Beautaholics stated the mask was a cosmetic device and UKCA certified, it was not registered with the Medicines and Healthcare products Regulatory Agency (MHRA) as required for medical devices making treatment claims. The company removed the social media ad and revised its website content to remove medical references, acknowledging the initial wording was inappropriate.
The ASA ruled that the ads breached CAP Code (Edition 12) rule 12.1, which prohibits medicinal or medical claims for unlicensed products. The regulator instructed Beautaholics not to repeat the claims and to ensure future ads comply with medical device regulations.
THE WHY? The ruling underscores the ASA’s increased scrutiny of skincare devices making clinical or therapeutic claims without MHRA registration, reflecting a wider compliance push in the fast-growing LED beauty technology sector.
Source: ASA



































